搜尋結果
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
Forbes· 17 小時前The conference was a big one for Summit Therapeutics, which saw its stock price more ... ...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters· 6 日前, opens new tab said it expects its cancer drug Lorbrena to top $1 billion in annual sales by ...
Gaza’s doctors were building a health system. Then came war.
Reuters· 2 日前Israel closed Gaza’s borders with Egypt’s help, curtailed people’s
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 4 日前More patients can fend off the disease for months or years with targeted or immune-boosting ...
Pharma Billionaire's Fortune More Than Doubles In A Day On Cancer Drug Trial News
Forbes· 7 日前The 272% surge in Summit’s stock more than doubled the fortune ...
Taiwan’s opposition gives William Lai and his DPP minority government a headache
South China Morning Post· 5 日前The opposition’s legislative package moves the Taiwanese legislature ...
China Market Update: MSCI Index Rebalance Weighs On Hong Kong, Week In Review
Forbes· 6 日前Asian equities were largely higher on high volumes driven by MSCI’s semi-index rebalance, as Japan outperformed ...
Why CEO AstraZeneca believes the drugmaker can almost double revenue by 2030
CNBC· 2 日前AstraZeneca CEO Pascal Soriot explained in a Tuesday interview with CNBC's Jim Cramer why t ...